This approach has been applied to a multitude of research areas including clinical studies of colorectal cancer, ovarian cancer, and breast cancer [23–25] and basic research studies such as naïve CD4 T cells and B cells [29, 30]. This evidence concerns the gene CD4 and ovarian carcinoma.